Lotus Holdings Co

Lotus Holdings Co FCF Conversion

The FCF Conversion Rate (FCF/EBITDA) of Lotus Holdings Co (600186.SS) as of Nov 1, 2026 is 67.74 %. In the previous year, FCF Conversion Rate (FCF/EBITDA) was 4.39 % — a change of 1,442.50% (higher).

FCF Conversion

67.74 %

YoY

1,442.50%

Last updated:

FCF Conversion Rate (FCF/EBITDA) of Lotus Holdings Co is 2025 67.74 % . FCF Conversion Rate (FCF/EBITDA) of Lotus Holdings Co was 2024 4.39 % . It decreases by 1,442.50% higher compared to the previous year.

The Lotus Holdings Co FCF Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Conversion
Date
FCF Conversion
Jan 1, 2018
8.78 CNY
Jan 1, 2019
-140.29 CNY
Jan 1, 2020
-1,190.55 CNY
Jan 1, 2021
-70.92 CNY
Jan 1, 2022
29.00 CNY
Jan 1, 2023
-27.80 CNY
Jan 1, 2024
4.39 CNY
Jan 1, 2025
67.74 CNY
The Lotus Holdings Co FCF Conversion history
YEARFCF ConversionYoY
67.74 %+1,442.50%
4.39 %-115.79%
-27.80 %-195.87%
29.00 %-140.89%
-70.92 %-94.04%
-1,190.55 %+748.60%
-140.29 %-1,697.28%
8.78 %-79.14%
42.10 %-163.67%
-66.13 %-5,311.97%
1.27 %-100.42%
-303.94 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Lotus Holdings Co Stock analysis

What does Lotus Holdings Co do? Lotus Health Group Co. develops and manufactures condiment products under the Lotus Flower brand, primarily monosodium glutamate. The company offers a range of products including chicken essence, soy sauce, vinegar, sodium glutamate, glutamic acid, amylaceum, cube sugar, flour, gluten powder, starch, vegetarian products, feed, and fertilizer. These products are distributed in domestic and overseas markets, targeting consumers and businesses seeking condiment and food ingredients. The firm's revenue comes from the sale of these branded condiment products to retail and wholesale customers within China and international markets. The company's product portfolio includes monosodium glutamate as its principal offering under the Lotus Flower brand, alongside complementary items like soy sauce and chicken essence. These products are sold through domestic retail channels and exported to overseas markets, generating income from both local and international sales. The firm's focus on condiment manufacturing and distribution supports its revenue streams across multiple product categories. Lotus Health Group Co. distributes its condiment products in domestic and overseas markets, with the Lotus Flower brand being central to its monosodium glutamate sales. The company's revenue is derived from the sale of its branded condiment products, including chicken essence, soy sauce, vinegar, and other food ingredients, to both domestic and international customers. The firm's product range caters to consumer and business segments requiring condiment and food ingredient solutions. Lotus Holdings Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Lotus Holdings Co stock

FCF Conversion Rate (FCF/EBITDA) of Lotus Holdings Co is 67.74 % in 2025.

FCF Conversion Rate (FCF/EBITDA) of Lotus Holdings Co changed from 4.39 % to 67.74 %, representing a 1,442.50% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of FCF Conversion Rate (FCF/EBITDA) Lotus Holdings Co since 2006 – with annual values, charts, and detailed analysis.

FCF conversion measures how effectively EBITDA converts to free cash flow. Higher conversion indicates efficient capital allocation and low maintenance costs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare FCF Conversion Rate (FCF/EBITDA)'s Lotus Holdings Co with sector peers and the industry average to assess whether it is attractive.

To evaluate FCF Conversion Rate (FCF/EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for FCF Conversion Rate (FCF/EBITDA).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Lotus Holdings Co

All Key Metrics — Lotus Holdings Co